[Federal Register Volume 84, Number 246 (Monday, December 23, 2019)]
[Notices]
[Pages 70552-70553]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-27554]
[[Page 70552]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-20-20DV; Docket No. CDC-2019-0114]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled ``Chronic Q Fever in the United
States: Enhanced Clinical Surveillance.'' This enhanced medical
surveillance for chronic Q fever will collect specific clinical data
not otherwise collected during routine public health surveillance to
allow for better characterization of the clinical presentation and risk
factors of chronic Q fever in the United States.
DATES: CDC must receive written comments on or before February 21,
2020.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2019-
0114 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, of the Information
Collection Review Office, Centers for Disease Control and Prevention,
1600 Clifton Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-
7570; Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected; and
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses.
5. Assess information collection costs.
Proposed Project
Chronic Q Fever in the United States: Enhanced Clinical
Surveillance--New--National Center for Emerging Zoonotic and Infectious
Diseases (NCEZID), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
Q fever is a worldwide zoonosis caused by Coxiella burnetii with
acute and chronic disease presentations. Chronic Q fever can manifest
months to years after the primary infection and is rare, occurring in
<5% of persons with an acute infection. Chronic Q fever can take on
several clinical forms, including endocarditis, chronic hepatitis,
chronic vascular infections, osteomyelitis, and osteoarthritis. In the
United States, Q fever cases are reported via the National Notifiable
Disease Surveillance System; however, limited information is collected
on the various clinical manifestation of chronic Q fever or patients
pre-existing risk factors. Data on outcomes other than death or
hospitalizations are not collected by the current surveillance.
Because of this lack of data, the true burden and proportion of
cases exhibiting endocarditis and other forms of chronic Q fever in the
United States is unknown. We plan to establish an enhanced medical
surveillance for chronic Q fever by working with consulting clinicians
to gather additional and more specific clinical data not otherwise
collected during routine public health surveillance for chronic Q
fever. This information will allow for better characterization of the
clinical presentation and risk factors of chronic Q fever in the United
States. The results will help characterize an under-recognized disease
and provide valuable data to educate physicians on identifying and
diagnosing these cases. CDC is requesting approval for five burden
hours annually. There is no cost to respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
Physician..................... Chronic Q fever 15 1 20/60 5
enhanced
surveillance
report form.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 5
----------------------------------------------------------------------------------------------------------------
[[Page 70553]]
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2019-27554 Filed 12-20-19; 8:45 am]
BILLING CODE 4163-18-P